| Previous close | 50.70 |
| Open | 51.40 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 51.40 - 51.40 |
| 52-week range | 51.40 - 51.40 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 7.653M |
| Beta (5Y monthly) | -0.15 |
| PE ratio (TTM) | 0.07 |
| EPS (TTM) | 7.16 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/ForecastDrägerwerk AG & Co. KGaA: Correction of a prior-year figure in the ad-hoc notification dated April 17, 2023. All other content unchanged.05-May-2023 / 16:18 CET/CESTCorrection of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Due to an editorial error, the German version of t
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): AGM/EGM/DividendDrägerwerk AG & Co. KGaA: Dräger's Annual General Meeting approves stable dividend for fiscal year 2022 05.05.2023 / 16:07 CET/CESTThe issuer is solely responsible for the content of this announcement.Dräger's Annual General Meeting approves stable dividend for fiscal year 2022Lübeck—Drägerwerk AG & Co. KGaA held its Annual General Meeting 2023 today. All resolutions on the agenda items were passed with a vast majority. In total,
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Quarter Results/ForecastDrägerwerk AG & Co. KGaA: Dräger with strong net sales growth and positive earnings in the first quarter of 2023 28.04.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dräger with strong net sales growth and positive earnings in the first quarter of 2023 Net sales increase of 18 percent compared to the same quarter in the previous year Net sales growth across both divisions and all
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/ForecastDrägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed17-Apr-2023 / 17:49 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Ad-hoc notification in accordance with Sec. 17 of the MARDräg
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Annual Report/ForecastDrägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023 09.03.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dräger expects return to profitable growth in 2023 Order intake up in fiscal year 2022 despite difficult conditions Net sales and earnings significantly below prior year, in particular due to disrupted supply chains Significant increase in net sales and
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/ForecastDrägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability17-Jan-2023 / 16:07 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announ
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Corporate ActionDrägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed 03.01.2023 / 09:27 CET/CESTThe issuer is solely responsible for the content of this announcement.Dräger redeems last participation certificates – streamlining of capital structure completedLübeck—Yesterday, Drägerwerk AG & Co. KGaA redeemed all 382,289 remaining series D profit participation certificates as planne
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): MiscellaneousDrägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052 28.11.2022 / 14:34 CET/CESTThe issuer is solely responsible for the content of this announcement.Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052Purchase of own shares –
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): 9 Month figures/Quarter ResultsDrägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022 27.10.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dräger expects faster sales recognition in the fourth quarter of 2022 Noticeable increase in order intake in the first nine months Net sales and earnings significantly below prior year, in particular due to disrupted supply ch
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/ForecastDrägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable14-Oct-2022 / 18:00 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announc
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): MiscellaneousDrägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission 29.09.2022 / 14:26 CET/CESTThe issuer is solely responsible for the content of this announcement.Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the CommissionOn September 26, 2022
DGAP-News: Drägerwerk AG & Co. KGaA / Key word(s): Half Year Report/Half Year ResultsDrägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022 28.07.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Dräger expects significant recovery in business development in the second half of 2022 Order intake in the first half of the year significantly above prior-year level and own expectations Significant decline in ne
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/ForecastDrägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H214-Jul-2022 / 20:58 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this anno